Faslodex 250® Fulvestrant Injection

Faslodex 250 mg contains fulvestrant, a hormonal anticancer medicine used to treat hormone receptor-positive, locally advanced or metastatic breast cancer in eligible women. It binds to oestrogen receptors and promotes their breakdown, reducing the stimulation of cancer cells by oestrogen.

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.